Ex Vivo T-Cell Transfection Kit — Antibody-Conjugated ctLNP
Ready-to-use antibody-conjugated ctLNP suspension for ex vivo engineering of primary human T cells — ≥85% mRNA transfection, ≥90% viability, covers CD3+ / CD4+ / CD8+ subsets. Simple mixing, no equipment.
Catalog no. TD-TCE · Ships with certificate of analysis
For Research Use OnlyOverview
Overview
For ex vivo workflows — T cells harvested and engineered in culture before re-infusion — this ready-to-use antibody-conjugated ctLNP suspension transfects primary human T cells by simple mixing. No LNP preparation, no microfluidics, no electroporation.
Specifications
| Target cells | human primary T cells — CD3+ / CD4+ / CD8+ subsets |
|---|---|
| Conjugation chemistry | Mal-PEG lipid–antibody conjugation |
| mRNA transfection efficiency | ≥85% (>87% GFP-expressing cells at 24 h; peak 97.3%) |
| Cell viability post-transfection | ≥90% — proliferation and killing function unaffected |
| Nucleic acids | mRNA, sgRNA, siRNA |
| Format | ready-to-use suspension — simple mixing, no equipment |
Applications
CAR-T and TCR-T construction; gene knockout (sgRNA) and T-cell functional validation; tumour immunology and ex vivo T-cell research.
In vivo or ex vivo?
This kit is for engineering T cells outside the body. For in vivo T-cell targeting programmes, see our In Vivo tLNP Control Kits.
Notes
- Packaging specifications and COA are confirmed at enquiry.
- Efficiency figures refer to day-3 CD3/CD28-activated primary T cells; our in vivo kits report 99.5% on resting CD8+ T cells — different experimental conditions, compare with care.
- For Research Use Only. Not a drug and not a medical device; supplied exclusively for research applications.
- Certification documents available on request and verifiable by certificate number. FOB pricing, MOQ and lead time quoted at enquiry.
| Product | Ex Vivo T-Cell Transfection Kit — Antibody-Conjugated ctLNP |
|---|---|
| Catalog no. | TD-TCE |
| Category | Targeted Delivery |
| Documentation | Certificate of analysis provided with every lot |
| Intended use | For Research Use Only (RUO). Not for diagnostic or therapeutic use. |
Related products
Lung-Targeted RNA Transfection Kit (Ready-to-Use LNP)
Ready-to-use lung-targeted LNP kit — one mixing step, no microfluidics, no incubation, ethanol-free. Up to 94% lung accumulation after IV administration in animals. siRNA, gRNA, mRNA and circRNA compatible.
Spleen-Targeted RNA Transfection Kit (Ready-to-Use LNP)
Ready-to-use spleen-targeted LNP kit — mix, incubate 15 minutes, inject. Up to 97.60% spleen accumulation with low liver and kidney toxicity. No equipment required. mRNA, siRNA and circRNA compatible.
Lymph Node-Targeted RNA Transfection Kit (Ready-to-Use LNP)
Ready-to-use lymph-node-targeted LNP kit — mix, incubate 15 minutes, inject. Efficient expression in lymph nodes with markedly reduced off-target liver accumulation. No equipment required. mRNA, siRNA and circRNA compatible.
Get a quote for Ex Vivo T-Cell Transfection Kit — Antibody-Conjugated ctLNP
Specs, pricing, lead time and shipping options — usually within one business day.